| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 18, 2005
Accepted on April 20, 2005
Department of Clinical and Experimental Medicine "F. Magrassi & A. Lanzara" (G.M., F.S., M.P., G.A., C.C.); Department of Clinical Pathology (M.C., A.M.), Department of Infectious Disease (G.S., G.B.G.), Second University of Naples, Italy; Department of Food Science (F.M.), University "Federico II" of Naples, Italy; Department of Medicine (J.H.L.), University of Wales College of Medicine, Cardiff, United Kingdom
* To whom correspondence should be addressed. E-mail: carlo.carella{at}unina2.it.
Objective. In this prospective study, we investigated whether the development of interferon-alfa (IFN-
)-related autoimmune thyroiditis (IFN-AT) was correlated with the sequential changes of cytokine pattern induced by the IFN-
in the peripheral lymphocytes.
Patients and methods. We enrolled 18 HCV+ patients who developed IFN-AT, of whom 8 with euthyroidism [IFN-AT(Eu)] and 10 patients with thyroid dysfunction [IFN-AT(Dy)]. Twenty HCV+ patients without IFN-AT acted as control group (Co-HCV+). Intracellular expression of IFN-
and IL-4 was evaluated by multicolour flow-cytometry analysis in peripheral lymphocytes in vitro stimulated by PMA (25 ng/ml) and ionomycin (1 µg/ml), in presence of monensin (5 µM).
Results. At the appearance of thyroid disease, both IFN-AT(Eu) and IFN-AT(Dy) patients showed a significant increase of IFN-
expression in CD3+CD56+ and CD3-CD56+ cells but not in CD4+ and CD8+ cells. At this time-point, IFN-AT(Eu) but not IFN-AT(Dy) patients showed also an increase of IL-4 expression in CD3+CD56+ cells and CD4+ cells. Six months later, IFN-AT(Eu) patients maintained high expression of IL-4 in CD4+ and CD3+CD56+ cells, without any further increase in IFN-
expression. By contrast, IFN-AT(Dy) patients showed an increase of IFN-
expression in CD4+ and CD8+ cells, with a concomitant decrease of IL-4 expression in CD4+ cells.
Conclusions. Type-2 immune response is activated early and specifically in patients with IFN-AT who remain euthyroid throughout the follow-up. In patients developing thyroid dysfunction, by contrast, is predominant the type-1 immune response that seems to occur earlier in innate than in acquired immune system.
This article has been cited by other articles:
![]() |
K. Yamazaki, K. Suzuki, E. Yamada, T. Yamada, F. Takeshita, M. Matsumoto, T. Mitsuhashi, T. Obara, K. Takano, and K. Sato Suppression of Iodide Uptake and Thyroid Hormone Synthesis with Stimulation of the Type I Interferon System by Double-Stranded Ribonucleic Acid in Cultured Human Thyroid Follicles Endocrinology, July 1, 2007; 148(7): 3226 - 3235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rotondi, R. Minelli, F. Magri, P. Leporati, P. Romagnani, M. C. Baroni, R. Delsignore, M. Serio, and L. Chiovato Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-{alpha} therapy for hepatitis C virus-related hepatitis Eur. J. Endocrinol., April 1, 2007; 156(4): 409 - 414. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |